Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Helios Technologies, Inc. - HLIO


NEW YORK, Aug. 1, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Helios Technologies, Inc. ("Helios" or the "Company") (NYSE: HLIO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Helios and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On July 8, 2024, Helios issued a press release announcing that its Board of Directors had "place[d] Josef Matosevic, the Company's President, Chief Executive Officer and Director, immediately on a paid leave effective July 1, 2024, as a result of allegations of a potential violation of the Company's Code of Business Conduct and Ethics." Helios stated that "Mr. Matosevic's leave is pending completion of an ongoing investigation being conducted by the Board with the assistance of outside legal counsel." 

On this news, Helios's stock price fell $5.07 per share, or 10.94%, to close at $41.26 per share on July 9, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 04:04
Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration...

at 03:47
The 90th China International Medical Equipment Fair (CMEF) has successfully kicked off in Shenzhen, running from October 12-15. This year's event spans nearly 200,000 square meters and hosts nearly 4,000 exhibitors with an audience surpassing 200,000...

12 oct 2024
Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Winnebago Industries, Inc. resulting from allegations that Winnebago may have issued materially misleading business...

12 oct 2024
Eulerity, the industry-leading platform for multi-location marketing, just announced strategic partnerships with several prominent brands. Famous Brands International, the parent company of Mrs. Fields and TCBY, along with HealthSource Chiropractic,...

12 oct 2024
PackCapture has launched a new order packing recording system designed to enhance accuracy and efficiency in warehouse operations. With real-time recording, comprehensive analytics, and seamless integration with existing systems, PackCapture enables...

12 oct 2024
...



News published on and distributed by: